BSO-07

• Target:

  JNK|||Reactive Oxygen Species

• Related Pathways:

  Immunology/Inflammation|||Metabolism|||NF-?B|||MAPK

• Bioactivity:

  BSO-07 is a ROS/JNK activator that exhibits potent anti-cancer properties, demonstrated by an IC50 of 24.81 ?M in human breast cancer (BC) cells. The mechanism of action for BSO-07 involves JNK activation and the promotion of increased ROS levels, which lead to the induction of apoptosis (Apoptosis) and tumorigenic apoptosis. This includes enhanced expression of apoptosis-related proteins such as PARP, Bax, phosphorylated p53, ATF4, and CHOP, along with a reduction in the levels of anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL, and Survivin) . BSO-07 holds promise for research in the field of breast cancer.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C